title: Microarray profiling of mononuclear peripheral blood cells identifies novel candidate genes related to chemoradiation response in rectal cancer.
abstract: Preoperative chemoradiation significantly improves oncological outcome in locally advanced rectal cancer. However there is no effective method of predicting tumor response to chemoradiation in these patients. Peripheral blood mononuclear cells have emerged recently as pathology markers of cancer and other diseases, making possible their use as therapy predictors. Furthermore, the importance of the immune response in radiosensivity of solid organs led us to hypothesized that microarray gene expression profiling of peripheral blood mononuclear cells could identify patients with response to chemoradiation in rectal cancer. Thirty five 35 patients with locally advanced rectal cancer were recruited initially to perform the study. Peripheral blood samples were obtained before neaodjuvant treatment. RNA was extracted and purified to obtain cDNA and cRNA for hybridization of microarrays included in Human WG CodeLink bioarrays. Quantitative real time PCR was used to validate microarray experiment data. Results were correlated with pathological response, according to Mandard´s criteria and final UICC Stage (patients with tumor regression grade 1-2 and downstaging being defined as responders and patients with grade 3-5 and no downstaging as non-responders). Twenty seven out of 35 patients were finally included in the study. We performed a multiple t-test using Significance Analysis of Microarrays, to find those genes differing significantly in expression, between responders (n = 11) and non-responders (n = 16) to CRT. The differently expressed genes were: BC 035656.1, CIR, PRDM2, CAPG, FALZ, HLA-DPB2, NUPL2, and ZFP36. The measurement of FALZ (p = 0.029) gene expression level determined by qRT-PCR, showed statistically significant differences between the two groups. Gene expression profiling reveals novel genes in peripheral blood samples of mononuclear cells that could predict responders and non-responders to chemoradiation in patients with locally advanced rectal cancer. Moreover, our investigation added further evidence to the importance of mononuclear cells' mediated response in the neoadjuvant treatment of rectal cancer.
authors.affiliation: Division of Colon and Rectal Surgery, HUVN, Granada, Spain.
authors.forename: Pablo
authors.initials: P
authors.lastname: Palma
authors.forename: Marta
authors.initials: M
authors.lastname: Cuadros
authors.forename: Raquel
authors.initials: R
authors.lastname: Conde-Muíño
authors.forename: Carmen
authors.initials: C
authors.lastname: Olmedo
authors.forename: Carlos
authors.initials: C
authors.lastname: Cano
authors.forename: Inmaculada
authors.initials: I
authors.lastname: Segura-Jiménez
authors.forename: Armando
authors.initials: A
authors.lastname: Blanco
authors.forename: Pablo
authors.initials: P
authors.lastname: Bueno
authors.forename: J Antonio
authors.initials: JA
authors.lastname: Ferrón
authors.forename: Pedro
authors.initials: P
authors.lastname: Medina
mesh_terms: D000328:Adult; D000368:Aged; D014408:Biomarkers, Tumor; D005260:Female; D020869:Gene Expression Profiling; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects* / Q000528:radiation effects*; D006801:Humans; D007963:Leukocytes, Mononuclear / Q000187:drug effects / Q000378:metabolism* / Q000528:radiation effects; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011379:Prognosis; D012004:Rectal Neoplasms / Q000188:drug therapy / Q000235:genetics* / Q000532:radiotherapy; D015203:Reproducibility of Results; D016896:Treatment Outcome
chemical_list: D014408:Biomarkers, Tumor
references.citation: N Engl J Med. 2004 Oct 21;351(17):1731-40
references.pmid: 15496622
references.citation: Pharmacogenomics. 2007 Apr;8(4):319-27
references.pmid: 17391070
references.citation: Clin Cancer Res. 2007 Mar 1;13(5):1493-502
references.pmid: 17332294
references.citation: Clin Cancer Res. 2008 Aug 1;14(15):4883-90
references.pmid: 18676762
references.citation: N Engl J Med. 2001 Aug 30;345(9):690-2
references.pmid: 11547725
references.citation: Int J Radiat Oncol Biol Phys. 2002 Oct 1;54(2):403-8
references.pmid: 12243814
references.citation: Nucleic Acids Res. 2011 Jan;39(Database issue):D1005-10
references.pmid: 21097893
references.citation: Oncogene. 2001 Oct 25;20(48):7085-95
references.pmid: 11704832
references.citation: Int J Radiat Oncol Biol Phys. 1999 Jul 15;44(5):1027-38
references.pmid: 10421535
references.citation: N Engl J Med. 2001 Aug 30;345(9):638-46
references.pmid: 11547717
references.citation: Oncogene. 2004 Nov 11;23(53):8673-80
references.pmid: 15467755
references.citation: Cancer Res. 2003 Sep 15;63(18):6069-75
references.pmid: 14522937
references.citation: N Engl J Med. 2001 Feb 22;344(8):539-48
references.pmid: 11207349
references.citation: Cancer Res. 2005 Apr 1;65(7):2542-6
references.pmid: 15805246
references.citation: Int J Radiat Oncol Biol Phys. 2002 Jul 1;53(3):664-74
references.pmid: 12062610
references.citation: Mol Biol Cell. 2007 Nov;18(11):4648-58
references.pmid: 17855506
references.citation: BMC Cancer. 2003 Feb 7;3:3
references.pmid: 12657164
references.citation: PLoS One. 2011 Feb 10;6(2):e17014
references.pmid: 21347333
references.citation: Ann Surg Oncol. 2012 Apr;19(4):1192-8
references.pmid: 21913011
references.citation: Oncol Rep. 2007 May;17(5):1089-94
references.pmid: 17390049
references.citation: Cancer. 2003 Jan 15;97(2):517-24
references.pmid: 12518377
references.citation: Arch Surg. 2008 Mar;143(3):227-33; discussion 233-4
references.pmid: 18347268
references.citation: Nat Med. 2007 Sep;13(9):1050-9
references.pmid: 17704786
references.citation: J Clin Oncol. 2010 Apr 1;28(10):1638-44
references.pmid: 20194850
references.citation: Int J Radiat Biol. 2007 Nov-Dec;83(11-12):819-25
references.pmid: 17852561
references.citation: BMC Cancer. 2011 Feb 10;11:64
references.pmid: 21306650
references.citation: J Clin Oncol. 2005 Dec 1;23(34):8688-96
references.pmid: 16246976
references.citation: APMIS. 2009 Jan;117(1):53-9
references.pmid: 19161537
references.citation: Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5116-21
references.pmid: 11309499
references.citation: Oncologist. 2007 Nov;12(11):1309-18
references.pmid: 18055850
references.citation: J Clin Oncol. 2007 Mar 1;25(7):862-8
references.pmid: 17327607
references.citation: Free Radic Biol Med. 2011 May 1;50(9):1186-95
references.pmid: 21295136
references.citation: Mol Med. 2007 Jan-Feb;13(1-2):40-58
references.pmid: 17515956
references.citation: J Clin Oncol. 2005 Mar 20;23(9):1826-38
references.pmid: 15774776